
    
      Between June to Dec 2018, 200 participants those met the eligibility criteria were enrolled
      in this study that is a quasi experimental study. All participants were empirical antibiotic
      therapy by infectious physician. 100 patients in Pre-intervention group had bacterial
      identification by Mass spectrometry technique from bacterial colony and 100 patients in
      Post-intervention group had bacterial identification by Microarray assay from blood culture.
      Antibiotic adjustment were considered after bacterial identification and result of antibiotic
      susceptibility testing. Then all participants were re-evaluated outcome after treatment.
      Finally, the results were ready to analysis in January 2019.
    
  